Secondary hypertension — evaluation & workup
Identifiable cause screen · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Secondary hypertension is raised BP from an identifiable cause, found in ~10% of hypertensives. Clues include young onset, resistant or accelerated hypertension, hypokalaemia, or clinical features of an endocrine or renal disorder; targeted testing can yield curable causes.
Red flags
- Paroxysmal headache, palpitations and sweating (phaeochromocytoma)
- Flash pulmonary oedema with preserved LV function (bilateral renal artery stenosis)
- Spontaneous or diuretic-induced hypokalaemia
- Hypertension with abdominal or flank bruit
- Accelerated hypertension in a patient under 40
Assessment
Differential diagnosis
- Primary aldosteronism (Conn)
- Renal artery stenosis / renovascular
- Chronic kidney disease
- Phaeochromocytoma/paraganglioma
- Obstructive sleep apnoea
- Cushing syndrome
- Aortic coarctation / thyroid disease
Investigations
- Plasma aldosterone-to-renin ratio (off interfering drugs)
- U&E with attention to hypokalaemia and renal function
- Renal artery imaging (duplex, CT or MR angiography)
- Plasma free metanephrines or 24h urinary metanephrines
- Overnight dexamethasone suppression or late-night salivary cortisol
- TFTs, and sleep study if OSA suspected
Management
- Identify red-flag features prompting workup: young age, resistant, accelerated, hypokalaemia
- Stop or account for drugs affecting the aldosterone-renin ratio where feasible
- Measure aldosterone-to-renin ratio as first-line screen for primary aldosteronism
- Assess renal function and urinalysis for intrinsic renal disease
- Image renal arteries if bruit, flash pulmonary oedema or rising creatinine on ACEi
- Screen for phaeochromocytoma with plasma/urinary metanephrines if paroxysmal symptoms
- Screen for Cushing with dexamethasone suppression if phenotype present
- Evaluate for OSA with validated questionnaire and polysomnography
- Measure four-limb BP and image aorta if coarctation suspected
- Refer confirmed endocrine causes for confirmatory testing and subtyping
- Treat the underlying cause and continue antihypertensives as needed
- Avoid over-investigation in older patients with classic essential hypertension
Drugs & doses
Spironolactone 25-50 mg PO OD (aldosteronism, while awaiting intervention)
Phenoxybenzamine 10 mg PO BD titrated (alpha blockade before pheochromocytoma surgery)
Doxazosin MR 4-8 mg PO OD (alternative alpha blockade)
Amlodipine 5-10 mg PO OD (non-interfering agent during ARR testing)
Verapamil SR 120-240 mg PO OD (non-interfering agent during ARR testing)
Disposition
Refer to hypertension specialist, endocrinology or nephrology depending on cause. Surgical referral for adenoma, stenosis or coarctation as indicated.
Complications & pitfalls
- Hypertensive emergency / target-organ damage
- Hypertensive crisis during pheochromocytoma manipulation
- Progressive renal impairment
- Stroke and cardiovascular events
- Delayed diagnosis of curable cause
Exam pearls
- Never give a beta-blocker before alpha blockade in phaeochromocytoma
- A low or suppressed renin with high aldosterone suggests primary aldosteronism
- ACEi-induced acute kidney injury flags bilateral renal artery stenosis
- Primary aldosteronism is far more common than historically taught — screen liberally
- Confirm positive screens before committing to surgery or lifelong therapy
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.